Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
Clinical trial NCT06365788 · RECRUITING
Trial details
- NCT number
- NCT06365788
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-08
- Primary completion
- 2027-12-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.